Prevalence and Outcomes of Subclinical Interstitial Lung Disease in COPDGene
J.A. Rose(Brigham and Women's Hospital), Gary M. Hunninghake(Hubei University of Science and Technology), Iván O. Rosas(Brigham and Women's Hospital), G.R. Washko(Brigham and Women's Hospital), Rachel K. Putman(Brigham and Women's Hospital), H. Hatabu(Brigham and Women's Hospital), Takuya Hino(Harvard University), Akinori Hata(Osaka University), E.K. Silverman(Brigham and Women's Hospital), M.H. Cho(Brigham and Women's Hospital), Adil Menon(Brigham and Women's Hospital), Mari Nishino(Dana-Farber Cancer Institute), David A. Lynch(McMaster University)
Cited by 1
Related Papers
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
|American Journal of Respiratory and Critical Care Medicine|2013|4.3k
Genetic Epidemiology of COPD (COPDGene) Study Design
|COPD Journal of Chronic Obstructive Pulmonary Disease|2010|1.3k
Comorbidities and Risk of Mortality in Patients with Chronic Obstructive Pulmonary Disease
|American Journal of Respiratory and Critical Care Medicine|2012|1.3k
BUILD-3: A Randomized, Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis
|American Journal of Respiratory and Critical Care Medicine|2011|713
Serum Vitamin D Levels and Markers of Severity of Childhood Asthma in Costa Rica
|American Journal of Respiratory and Critical Care Medicine|2009|635